These Form 3 filings are routine and carry no immediate trading signal. Monitor future Form 4 filings for open-market purchases or sales by these insiders, which would provide clearer conviction signals.
Price Chart
Executive Summary
Three Form 3 initial beneficial ownership filings for Latigo Biotherapeutics (LTGO) were filed on August 6, 2026, by CEO Nima Farzan and directors Sara Bonstein and Todd N. Smith. The filings disclose insider holdings and option grants but contain no trading activity or material corporate events — they are routine administrative filings triggered by the insiders' positions.
Key Facts
- CEO Nima Farzan reports 114,453 shares of common stock held indirectly via a trust and options to purchase 2,787,966 shares at exercise prices of $2.19 and $5.53, vesting over time.
- Director Sara Bonstein reports options to purchase 105,542 shares at $8.16, vesting monthly over 48 months starting April 1, 2026.
- Director Todd N. Smith reports no direct or indirect ownership of LTGO securities.
- All three filings include powers of attorney authorizing company officers to execute future Section 16 filings.
Financial Impact
No financial impact — these are initial ownership disclosures with no transactions or material financial data.
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (LTGO) — Batch item 1 | 0001808296-26-000006 |
| Document: 0001808296-26-000006-index-headers.html | 0001604019-26-000012 |
| Document: 0001808296-26-000006-index.html | 0001523672-26-000006 |
| Document: 0001808296-26-000006.txt | 0001808296-26-000006 |
| 3 Filing (LTGO) — Batch item 5 | 0001604019-26-000012 |
| Document: 0001604019-26-000012-index-headers.html | 0001808296-26-000006 |
| Document: 0001604019-26-000012-index.html | 0001808296-26-000006 |
| Document: 0001604019-26-000012.txt | 0001808296-26-000006 |
| 3 Filing (LTGO) — Batch item 9 | 0001523672-26-000006 |
| Document: 0001523672-26-000006-index-headers.html | 0001808296-26-000006 |
| Document: 0001523672-26-000006-index.html | 0001808296-26-000006 |
| Document: 0001523672-26-000006.txt | 0001808296-26-000006 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 7w ago | Press Release | $23.04 $23.73 | ▲ +2.99% | ▲ +3.54% | $15.26 (−33.77%) |
Aug 12, 2026 10w ago | 3 | $19.38 $20.06 | ▲ +3.54% | ▲ +2.84% | $15.26 (−21.24%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.26 (−17.60%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.26 (−17.60%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.26 (−17.60%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.26 (−17.60%) |
Aug 10, 2026 11w ago | 8-K | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.26 (−17.60%) |
Aug 7, 2026 11w ago | EFFECT | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.26 (−16.38%) |
Aug 6, 2026 11w ago | 3 | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.26 (−16.38%) |
Aug 6, 2026 11w ago | 3 | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.26 (−16.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers